DC

DocGo Inc.

DCGOHealthcareNASDAQ

Medical Care Facilities

PriceMA150MA200
Loading chart…
End-of-day data · ScananceOpen live chart on TradingView ↗
Indicator snapshot · Today
Premium
Today's indicator reading is locked

Free plan shows historical signals only. Upgrade to see this ticker's current MA150, MA200, RSI, and MACD readings.

Upgrade to see today →
Financials · Annual
Revenue
$322.2M
-47.7% YoY
Net Income
-$182.4M
-1012.4% YoY
EBITDA
-$73.5M
-264.9% YoY
Free Cash Flow
$44.0M

Scan Results

Daily timeframe
5 recent days hidden. Fresh signals are a Premium featureUpgrade →
DateIndicatorDetails
Jul 7 MACD Positive CrossoverHistogram +0.0076, positive momentum
Jul 6 MACD Positive CrossoverHistogram +0.0036, positive momentum
About DocGo Inc.

Headquartered within the healthcare sector, DocGo Inc. focuses on Medical Care Facilities services and products. DocGo Inc. operates as a mobile healthcare services company in the United States and the United Kingdom. The $63.5M market capitalization puts DCGO squarely in micro-cap range for its industry. It operates through Mobile Health Services and Transportation Services segments.

Where DCGO stands vs its 150-day and 200-day moving averages

As of the July 7, 2026 close, DCGO finished 18.06% below its 150-day moving average ($0.72) and 29.76% below its 200-day moving average ($0.84). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.

Is DCGO overbought or oversold?

At the July 7, 2026 close, DCGO's RSI(14) was 51.5, in neutral territory (between 30 and 70). The MACD histogram was positive, so short-term momentum leaned bullish at that close. These readings are historical, refresh daily after market close, and are not investment advice.

Key stats
Market Cap$63.5M
Fwd P/E12.63
EPS$-1.83
Beta1.02
52W Change-56.0%
ROE-97.8%
Analysis

The balance sheet looks solid with $35.7M in cash comfortably exceeding the $28.5M debt load. A net cash position generally provides financial flexibility during uncertain economic periods. Annual free cash flow of $44.0M supports ongoing capital allocation decisions and provides a cushion against unexpected expenses or downturns. ROE of -97.8% points to negative capital efficiency, indicating how much profit the company produces per dollar of shareholder equity. Revenue has pulled back from $440.5M (2022) to $322.2M (2025), a 27% decline worth watching.

As with any equity investment, DCGO carries market risk, sector-specific risk, and company-specific risk that investors should evaluate in the context of their own portfolios. These risk factors are not exhaustive — macroeconomic shifts, regulatory changes, and competitive dynamics can all influence DocGo Inc.'s trajectory.

Links
More Healthcare stocks
Browse all stocks →
Not financial advice. Scanance shows end-of-day technical indicators (not real-time prices) for information only. Results can be wrong; past performance does not guarantee future results.PrivacyTerms
DCGO: DocGo Inc. Technical Analysis (200-Day MA, RSI, MACD) | Scanance